Significance Statement {#s1}
======================

Children who exhibit fetal alcohol spectrum disorders (FASD) are often diagnosed with comorbid attention deficit hyperactivity disorder (ADHD), even though mechanisms underlying attention deficits in these two disorders are now believed to differ. We show in mice after developmental binge-pattern ethanol exposure that deficits on an attention task are accompanied by dysregulated function of prefrontal cortex layer VI pyramidal neurons, which are known to be critical for normal attention. These layer VI neurons show decreased intrinsic excitability and increased responses to excitatory neurotransmission, and relationships between their nicotinic signaling and attention performance are disrupted. These findings demonstrate novel mechanisms and potential therapeutic targets to mitigate attention deficits associated with FASD.

Introduction {#s2}
============

Chronic prenatal exposure to ethanol can lead to a spectrum of teratogenic outcomes in humans known collectively as fetal alcohol spectrum disorders (FASD; [@B91]; [@B17]; [@B83]). Potential manifestations of FASD include growth deficiency, specific craniofacial abnormalities, and persistent neurocognitive deficits ([@B17]). The estimated prevalence of FASD ranges from approximately 31 to 34 per 1000 live births in the United States and Canada to 113 per 1000 live births in South Africa ([@B86]), and this is known to impart significant costs to individuals and societies within their local education, judicial, and medical systems ([@B50]; [@B80]). Deficits in attention rank among the most common and persistent neurocognitive components of FASD, for example, as a comorbid diagnosis of attention deficit hyperactivity disorder (ADHD) has been assigned to approximately 41--95% of children who are affected by FASD ([@B9]; [@B30]). However, recent work suggests that the detailed pattern of attention deficits is distinct between these two disorders, including earlier onset and greater impairment to shifting attention in children affected by FASD ([@B67]; [@B58]; [@B45]). Moreover, although medication indicated specifically for ADHD that targets dopaminergic and noradrenergic signaling may reduce hyperactivity in children affected by FASD, it shows limited efficacy to mitigate attention deficits within this same population ([@B90]; [@B68]; [@B23]). To identify appropriate therapeutic strategies for affected children, it therefore is critical to determine the specific neurobiological mechanisms that underlie attention systems dysfunction in FASD ([@B71]; [@B77]; [@B46]).

Optimal attention performance depends on pyramidal neurons located within layer VI of the medial prefrontal cortex (mPFC). Approximately 40% of neurons within this population modulate the gain of corticothalamic signaling through projections to the mediodorsal thalamus via the thalamic reticular nucleus ([@B31]; [@B95]; [@B70]; [@B88]), with the remaining 60% of neurons projecting to other targets including the hypothalamus, striatum, amygdala, and the prefrontal cortex itself ([@B31]; [@B37]). Layer VI neurons are stimulated directly by acetylcholine (ACh) activation of α4β2\* type heteromeric nicotinic acetylcholine receptors (nAChRs), which are heteropentamers composed of two α4 subunits, two β2 subunits, and a fifth accessory subunit denoted by the asterisk that for mPFC layer VI neurons may be either an α4, β2, or α5 subunit ([@B43]; [@B5]; [@B79]; [@B10]). This action of ACh at mPFC layer VI pyramidal neurons contributes to the critical role of prefrontal cholinergic signaling to support optimal attention performance in situations requiring high attentional demand ([@B21]; [@B72]; [@B5]; [@B38]; [@B32]). Acute ethanol exposure increases ACh efficacy at α4β2\* nAChRs ([@B1]; [@B15]; [@B96]), whereas chronic ethanol exposure decreases α4β2\* nAChR content ([@B85]; [@B36]) and may also decrease nAChR function *in vivo* ([@B52]). Chronic ethanol exposure during rat development impairs memory and attention in adulthood ([@B82]; [@B64]; [@B94]; [@B14]) and decreases the beneficial effects of nAChR stimulation to augment these mPFC-dependent functions ([@B65]). However, the long-term consequences of chronic developmental ethanol exposure to alter the function of mPFC layer VI pyramidal neurons, the function of nAChRs located on these neurons, and the ability of nicotinic signaling at these nAChRs to support attention behavior have not been determined. We find here that chronic developmental binge-pattern ethanol exposure in mice decreases performance on the five-choice serial reaction time test (5-CSRTT) for visual attention and dysregulates the function of mPFC layer VI pyramidal neurons, such that neurons show decreased intrinsic excitability along with increased responses to stimulation of both α4β2\* nAChRs and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptors. Correlations between α4β2\* nAChR function and performance on the 5-CSRTT are present in control mice but absent in mice exposed to ethanol during development, suggesting that this treatment disrupts the ability of nicotinic signaling in mPFC layer VI pyramidal neurons to support attention.

Materials and Methods {#s3}
=====================

Experimental animals and breeding {#s3A}
---------------------------------

C57BL/6 mice were purchased from Charles River Canada (Saint-Constant, QC, Canada) and bred in a secure vivarium at the University of Guelph. This facility had an ambient temperature of 21--24°C, and lights were maintained on a 12-h reverse light/dark cycle with lights on at 8:00 p.m. Nulliparous female mice aged 3--4 months were bred in pairs with male mice aged 4--5 months. Upon visual confirmation of a vaginal copulatory plug at the end of a dark cycle, female mice were separated to individual cages measuring 29 × 19 × 13 cm, and the next day was considered to be gestational day 1 (G1). All experimental animals in this study were cared for according to the principles and guidelines of the Canadian Council on Animal Care, and the experimental protocol was approved by the University of Guelph Animal Care Committee. Every effort was made to minimize animal suffering and limit the number of mice used in this study.

Developmental treatment regimens {#s3B}
--------------------------------

Pregnant female mice were randomly assigned to receive either ethanol or sucrose treatment via oral gavage from G10 to G18. Mice were administered ethanol at a dose of 2.0 g/kg/d \[24.4% (w/v)\] on G10 and G11, and 4.0 g/kg/d \[48.9% (w/v)\] from G12 to G18. Sucrose was administered in an amount that was isocaloric and isovolumetric to the ethanol treatment. Ethanol and sucrose solutions were made using tap water, and treatments were administered over two equally divided daily doses 2 h apart starting between 8:00 and 9:00 a.m. Mice in the ethanol treatment group received *ad libitum* access to water and pellet food (Tekland Global 18% Protein Rodent Maintenance Diet, Harlan Laboratories, Mississauga, ON, Canada). Mice in the sucrose treatment group received *ad libitum* access to water and were pair-fed with a mouse in the ethanol treatment group such that each mouse in the sucrose treatment group received the same amount of food as that eaten by its ethanol-treated pair for each day of gestation.

Pregnant mice and their litters were left undisturbed from G19 until postnatal day 4 (P4). The day of birth was considered to be P0. Individual pups were administered either ethanol or sucrose via oral gavage from P4 to P14 using a flexible plastic gavage needle (Instech Laboratories, Plymouth Meeting, PA). Postnatal treatment (ethanol or sucrose) was consistent with the prenatal treatment for each litter. Pups were administered ethanol at a dose of 1.5 g/kg/d \[7.5% (w/v)\] on P4 and P5 and 3.0 g/kg/d \[15% (w/v)\] from P6 to P14. Sucrose was administered in an amount that was isocaloric and isovolumetric to the ethanol treatment. Ethanol and sucrose solutions were prepared in Similac milk-based infant formula (Abbott Laboratories, Saint-Laurent, QC, Canada) using tap water. The milk formula within treatment solutions was prepared according to the manufacturer's recommendations, except that the concentration was doubled on P4 and P5 to mitigate any decrease in nursing that may occur at the onset of postnatal treatment. Treatments were administered over two equally divided daily doses 2 h apart starting between 8:00 and 9:00 a.m. All mice in this study were weighed and monitored daily for general health during the breeding and treatment periods. Litters were weaned and separated based on sex on P28 into cages measuring 29 × 19 × 13 cm with a maximum of five mice per cage. Offspring were provided *ad libitum* access to water and pellet food (Tekland Global 16% Protein Rodent Maintenance Diet) and, with the exception of monitoring for general health and body weight, were left undisturbed until behavioral training began on P60.

Blood ethanol concentration {#s3C}
---------------------------

Blood ethanol concentration (BEC) was measured for all dams on G15, which represents the midpoint for the 4 g/kg/d ethanol dosing regimen from G12 to G18. Ten microliters of blood was collected from the saphenous vein 1 h after the second daily gavage administration. BEC was measured in three naive litters not in this main study, which received ethanol treatment from P4 to P10. Pups were killed 1 h after the second daily gavage administration on P10 by decapitation under isoflurane anesthesia, and trunk blood was collected. P10 is the midpoint for the 3 g/kg/d ethanol dosing regimen for the pups from P6 to P14. For all analyses, 10 µl of blood was immediately added to 200 µl of 0.53N perchloric acid, mixed, and centrifuged at 14,000 × *g* for 15 min at 4°C. Supernatant (150 µl) was added to 150 µL of 0.53N potassium hydroxide, mixed, and stored at --80°C for later analysis. The concentration of short-chain alcohols in processed samples was measured using a microplate kit from Sigma-Aldrich Canada (Oakville, ON, Canada; product number MAK076) according to the manufacturer's recommendations.

Five-choice serial reaction time test {#s3D}
-------------------------------------

The 5-CSRTT was performed using Bussey--Saksida mouse touch screen--operant conditioning chambers (Lafayette Instrument Co., Lafayette, IN). Trapezoid-shaped chambers with 188-cm^2^ floor space housed a perforated stainless steel floor and a thin-film transistor touchscreen display on one wall. A plastic mask was fixed over the touchscreen that contained five square cut-outs measuring 4 × 4 cm, which created five distinct areas for light stimulus presentation and nose poke touch response. The opposite wall contained a reinforcer magazine equipped with a photodetector, light, and reward trough, where 7 μl of Neilson strawberry milkshake (Saputo Dairy Products Canada G.P., Saint-Laurent, QC, Canada) could be delivered by a peristaltic pump. Chambers were controlled by a personal computer running a 5-CSRTT application on the ABET II interface software (model 89543, Lafayette Instrument) and were housed in sound-attenuating cubicles equipped with a ventilation fan.

Starting at P60, 16 male mice from nine ethanol-treated litters and 16 male mice from eight sucrose-treated litters were pair-housed within cages measuring 29 × 19 × 13 cm with *ad libitum* access to water. Mice were randomly sampled as 1--3 mice per litter in the ethanol treatment group and 1--4 mice per litter in the sucrose treatment group. For the measures in this study that were significantly affected by developmental treatment, one-way ANOVA followed by Dunnett's *post hoc* test confirmed that the mean for no single litter was significantly different from the mean of its treatment group. Mice were food restricted to maintain a body weight of approximately 85% of their free-feeding body weight. Training on the 5-CSRTT was performed according to the 89543CAM 5-Choice Serial Reaction Time Task with Cambridge Amendment Manual (Lafayette Instrument) with minor alterations. Behavioral testing was performed 6 d per week (Sunday to Friday) and occurred at a similar time of day for each mouse between 9:00 a.m. and 3:00 p.m., which corresponded with the dark cycle for this study. The house light remained off for all sessions and was illuminated only during timeout periods. Training began with sessions of habituation to the chamber and reward delivery, which throughout this study was accompanied by the illumination of the magazine light and the emission of a short tone (3 KHz for 1 s). This was followed by one session of Pavlovian conditioning to link stimulus presentation with reward delivery. Daily touch-response training sessions began with a mouse placed in a chamber with one of five stimulus locations illuminated. A nose poke response in that stimulus location extinguished its light and resulted in reward delivery. Entrance into the magazine extinguished the magazine light and initiated a 5-s intertrial interval (ITI) to the next stimulus presentation. Stimuli were presented in a pseudorandom order, and mice were required to complete 30 trials within 60 min on two consecutive days to proceed. Daily training sessions for trial initiation built on the previous scheme, with the modification that the magazine light illuminated at the end of the ITI and a nose poke into the magazine was required to extinguish its light and start a 5-s delay to the next stimulus presentation. Mice were required to complete 30 trials within 60 min on two consecutive days to proceed.

Training sessions for the complete 5-CSRTT protocol began with a mouse placed in the chamber with the magazine light illuminated. A nose poke into the magazine extinguished its light and started the first trial with a 5-s delay to one of the five stimulus locations illuminating for a brief period. A nose poke response in that stimulus location while it was illuminated or during the following 5-s limited hold period resulted in reward delivery. Entrance into the magazine to collect the reward started a 5-s ITI, after which the magazine light illuminated and the mouse was required to re-enter the magazine to extinguish its light and start the next trial. A premature response made between trial initiation and stimulus presentation was not rewarded and led to a 5-s timeout period with the house light illuminated followed by a 5-s ITI, after which that same trial could be reinitiated by a nose poke into the magazine. An incorrect response in one of the four stimulus locations that was not illuminated or an error of omission in which no response was made by the end of the limited hold period was not rewarded and led to a 5-s timeout period with the house light illuminated, followed by a 5-s ITI, after which a magazine response initiated the next trial. Daily sessions lasted for 60 trials or 60 min, and each stimulus location was presented 12 times in a pseudorandom order. Accuracy percentage was calculated as \[number of correct responses/(number of correct responses + number of incorrect responses) × 100\]. Percentage of omissions was calculated as (omissions/total number of trials) × 100. Training began with an initial stimulus duration of 8 s, and this was gradually reduced depending on performance to a final stimulus duration of 1 s. The criterion to advance to the next stimulus duration was a performance of 60 trials with \>80% accuracy and \<20% omissions for three of four consecutive sessions.

Brain slice preparation for electrophysiology {#s3E}
---------------------------------------------

Mice were left undisturbed with *ad libitum* access to food and water for approximately 2 weeks after the completion of behavioral testing. Mice were killed by decapitation under isoflurane anesthesia, and brains were removed rapidly and cooled for 2 min in 4°C oxygenated sucrose artificial cerebral spinal fluid (ACSF; 254 m[m]{.smallcaps} sucrose, 10 m[m d]{.smallcaps}-glucose, 26 m[m]{.smallcaps} NaHCO~3~, 2 m[m]{.smallcaps} CaCl~2~, 2 m[m]{.smallcaps} MgSO~4~, 3 m[m]{.smallcaps} KCl, and 1.25 m[m]{.smallcaps} NaH~2~PO~4~, pH 7.4). Coronal slices containing the mPFC were cut in 4°C oxygenated sucrose ACSF at 400-μm thickness using a Leica VT 1200 vibrating microtome (Leica Microsystems, Concord, ON, Canada). The appearance of white matter and the corpus callosum were used as anterior and posterior landmarks ([@B76]; [@B31]). Slices were placed in a recovery chamber (Scientific Systems Design, Mississauga, ON, Canada) with 30°C oxygenated ACSF (128 m[m]{.smallcaps} NaCl, 10 m[m d]{.smallcaps}-glucose, 26 m[m]{.smallcaps} NaHCO~3~, 2 m[m]{.smallcaps} CaCl~2~, 2 m[m]{.smallcaps} MgSO~4~, 3 m[m]{.smallcaps} KCl, 1.25 m[m]{.smallcaps} NaH~2~PO~4~, pH 7.4) for at least 2 h before the beginning of electrophysiological recording.

Electrophysiology {#s3F}
-----------------

Brain slices were transferred to a modified recording chamber (Warner Instruments, Hamden, CT) mounted onto the stage of an Axioskop FS2 microscope (Carl Zeiss Canada, Toronto, ON, Canada) and superfused with oxygenated room-temperature ACSF at a rate of 3--4 ml/min. Pyramidal neurons in layer VI were visualized using infrared differential interference contrast microscopy and identified based on location within seven cell bodies (approximately 150 μm) from the medial aspect of the white matter and also by the presence of a prominent apical dendrite ([@B6]; [@B97]). Neurons were sampled from the anterior cingulate, prelimbic, and infralimbic cortical regions, and there was no effect of sampling location on any measure in this study. Whole-cell recording was performed using borosilicate glass pipette electrodes (2--5 MΩ; Sutter Instrument Company, Novato, CA) containing 120 m[m]{.smallcaps} K-gluconate, 5 m[m]{.smallcaps} KCl, 2 m[m]{.smallcaps} MgCl~2~, 4 m[m]{.smallcaps} K~2~-ATP, 400 μM Na~2~-GTP, 10 m[m]{.smallcaps} Na~2~-phosphocreatine, and 10 m[m]{.smallcaps} HEPES buffer (adjusted to pH 7.3 with KOH). Recordings were made using a Multiclamp 700B amplifier, acquired at 20 kHz, low-pass filtered at 2 kHz using a Digidata 1440A data acquisition system (Molecular Devices, Sunnyvale, CA), and corrected for the liquid junction potential. Neuron passive and active electrophysiological properties were first determined in current-clamp mode by measuring changes to membrane potential from rest in response to positive and negative current steps. Burst-firing neurons and fast-spiking interneurons were not used for subsequent analyses because they respond primarily to indirect nicotinic stimulation ([@B43]).

Neurons were next held at --75 mV in voltage-clamp mode for 5 min to record their baseline spontaneous excitatory postsynaptic currents (sEPSCs). Neurons remained at --75 mV, and receptor-mediated inward current responses were measured as follows: Nicotinic responses were probed by the addition of 1 m[m]{.smallcaps} ACh (Sigma-Aldrich Canada) after a minimum 10-min pre-exposure to 200 nM atropine; muscarinic responses were probed by the addition of 1 m[m]{.smallcaps} ACh after a minimum 10-min pre-exposure to 3 μM dihydro-β-erythroidine hydrobromide (DHβE; Tocris Bioscience/Bio-Techne, Minneapolis, MN); and AMPA glutamatergic responses were probed by the addition of 2 μM (S)-AMPA (Tocris Bioscience). All agonists were applied in the bath for 15 s. In mPFC layer VI pyramidal neurons, the nicotinic response to bath application of ACh is inhibited by the α4β2\* nAChR antagonist DHβE but not by the α7 nAChR antagonist methyllycaconitine ([@B43]; [@B5]; [@B79]), suggesting that all nicotinic responses in this study were mediated by α4β2\* nAChRs. Current responses were measured using Clampfit 10.3 software (Molecular Devices) as the change in holding current from baseline to the peak of the response. Receptor-mediated acceleration of action potential firing was measured in current-clamp mode by first injecting sufficient positive current to produce an approximate 1-Hz baseline firing frequency. After a minimum 30 s of stable baseline, each agonist was applied in the bath as described above. The percentage increase in firing frequency in response to agonist application was measured for each neuron as \[(frequency at the peak of the drug response -- frequency at baseline)/frequency at baseline\] × 100.

Statistical analysis {#s3G}
--------------------

BEC, pregnancy outcome, and offspring body weight data are presented as dam/litter mean ± 1 SEM of eight to nine litters for each treatment group, with the litter as the unit of determination for statistical analyses. Behavioral data on the 5-CSRTT are presented as mean ± 1 SEM of 14--16 male offspring from eight to nine litters for each treatment group, and electrophysiological data are presented as mean ± 1 SEM for 12 to 114 neurons from the same mice that were tested on the 5-CSRTT task. The unit of determination for statistical analyses was the mouse for behavioral experiments and the neuron for electrophysiology experiments. Data sets were first analyzed for normality and homogeneity of variance before statistical comparisons were performed. The statistical test used for each comparison is indicated in Results, tables, and figure legends, and all statistical tests along with their results are compiled in [Table 1](#T1){ref-type="table"}. These included the two-tailed unpaired *t* test (for normally distributed data sets), the Mann--Whitney *U* test (for non--normally distributed data sets), and the two-way repeated-measures ANOVA followed by the Bonferroni *post hoc* test. The Pearson correlation coefficient was used to assess relationships between electrophysiological measures and attention performance on the 5-CSRTT. Statistical analyses were performed using GraphPad Prism 6 (GraphPad Software, La Jolla, CA).

###### 

Statistics.

  Line   Location                                            Type of test                                                                             *p*-value
  ------ --------------------------------------------------- ---------------------------------------------------------------------------------------- --------------------------------------
  a      [Table 2](#T2){ref-type="table"}                    Two-tailed Mann-Whitney *U* test (gestation length)                                      0.3
  b      [Table 2](#T2){ref-type="table"}                    Two-tailed unpaired *t* test (litter size)                                               0.9
  c      [Table 2](#T2){ref-type="table"}                    Bonferroni's *post hoc* test (body weight at P4)                                         1.0
  d      [Table 2](#T2){ref-type="table"}                    Bonferroni's *post hoc* test (body weight at P14)                                        1.0
  e      [Table 2](#T2){ref-type="table"}                    Bonferroni's *post hoc* test (body weight at P21)                                        1.0
  f      [Table 2](#T2){ref-type="table"}                    Bonferroni's *post hoc* test (body weight at P28)                                        1.0
  g      [Table 2](#T2){ref-type="table"}                    Bonferroni's *post hoc* test (body weight at P60)                                        1.0
  h      [Fig. 2A](#F2){ref-type="fig"}                      Two-way repeated-measures ANOVA (stimulus duration)                                      *F*~(7,203)~ = 13.2; *p* \< 0.0001
  i      [Fig. 2A](#F2){ref-type="fig"}                      Two-way repeated-measures ANOVA (treatment)                                              *F*~(1,29)~ = 6.9; *p* = 0.01
  j      [Fig. 2A](#F2){ref-type="fig"}                      Bonferroni's *post hoc* test at 8 s                                                      *p* = 0.04
  k      [Fig. 2A](#F2){ref-type="fig"}                      Bonferroni's *post hoc* test at 1 s                                                      *p* = 0.0001
  l      [Fig. 2B](#F2){ref-type="fig"}                      Two-way repeated-measures ANOVA (stimulus duration)                                      *F*~(7,203)~ = 178.2; *p* \< 0.0001
  m      [Fig. 2B](#F2){ref-type="fig"}                      Two-way repeated-measures ANOVA (treatment)                                              *F*~(1,29)~ = 2.3; *p* = 0.1
  n      [Fig. 2B](#F2){ref-type="fig"}                      Two-way repeated-measures ANOVA (stimulus duration X treatment)                          *F*~(7,203)~ = 5.3; *p* \< 0.0001
  o      [Fig. 2B](#F2){ref-type="fig"}                      Bonferroni's *post hoc* test at 8 s                                                      *p* \<0.0001
  p      [Fig. 2C](#F2){ref-type="fig"}                      Two-way repeated-measures ANOVA (stimulus duration)                                      *F*~(7,203)~ = 26.7, *p* \< 0.0001
  q      [Fig. 2C](#F2){ref-type="fig"}                      Two-way repeated-measures ANOVA (treatment)                                              *F*~(1,29)~ = 0.2; *p* = 0.6
  r      [Fig. 2C](#F2){ref-type="fig"}                      Two-way repeated-measures ANOVA (stimulus duration × treatment)                          *F*~(7,203)~ = 2.8; *p* = 0.009
  s      [Fig. 2C](#F2){ref-type="fig"}                      Bonferroni's *post hoc* test at 8 s                                                      *p* = 0.005
  t      [Fig. 2D](#F2){ref-type="fig"}                      Two-way repeated-measures ANOVA (stimulus duration)                                      *F*~(7,203)~ = 38.4; *p* \< 0.0001
  u      [Fig. 2D](#F2){ref-type="fig"}                      Two-way repeated-measures ANOVA (treatment)                                              *F*~(1,29)~ = 7.1; *p* = 0.01
  v      [Fig. 2D](#F2){ref-type="fig"}                      Two-way repeated-measures ANOVA (stimulus duration × treatment)                          *F*~(7,203)~ = 3.2; *p* = 0.003
  w      [Fig. 2D](#F2){ref-type="fig"}                      Bonferroni's *post hoc* test at 1.2 s                                                    *p* = 0.04
  x      [Fig. 2D](#F2){ref-type="fig"}                      Bonferroni's *post hoc* test at 1.0 s                                                    *p* \< 0.0001
  y      [Fig. 2E](#F2){ref-type="fig"}                      Two-way repeated-measures ANOVA (stimulus duration)                                      *F*~(7,203)~ = 58.6; *p* \< 0.0001
  z      [Fig. 2E](#F2){ref-type="fig"}                      Two-way repeated-measures ANOVA (treatment)                                              *F*~(1,29)~ = 0.8; *p* = 0.4
  aa     [Fig. 2F](#F2){ref-type="fig"}                      Two-way repeated-measures ANOVA (stimulus duration)                                      *F*~(7,203)~ = 430.1; *p* \< 0.0001
  ab     [Fig. 2F](#F2){ref-type="fig"}                      Two-way repeated-measures ANOVA (treatment)                                              *F*~(1,29)~ = 0.01; *p* = 0.9
  ac     [Fig. 3A](#F3){ref-type="fig"}                      Two-way repeated-measures ANOVA (stimulus duration)                                      *F*~(7,203)~ = 73.1; *p* \< 0.0001
  ad     [Fig. 3A](#F3){ref-type="fig"}                      Two-way repeated-measures ANOVA (treatment)                                              *F*~(1,29)~ = 1.3; *p* = 0.3
  ae     [Fig. 3A](#F3){ref-type="fig"}                      Two-way repeated-measures ANOVA (stimulus duration × treatment)                          *F*~(7,203)~ = 2.5; *p* = 0.02)
  af     [Fig. 3A](#F3){ref-type="fig"}                      Bonferroni's *post hoc* test at 8 s                                                      *p* = 0.001
  ag     [Fig. 3B](#F3){ref-type="fig"}                      Two-way repeated-measures ANOVA (stimulus duration)                                      *F*~(7,203)~ = 42.8; *p* \< 0.0001
  ah     [Fig. 3B](#F3){ref-type="fig"}                      Two-way repeated-measures ANOVA (treatment)                                              *F*~(1,29)~ = 5.6; *p* = 0.03
  ai     [Fig. 3B](#F3){ref-type="fig"}                      Bonferroni's *post hoc* test at 1.6 s                                                    *p* = 0.02
  aj     [Fig. 3B](#F3){ref-type="fig"}                      Bonferroni's *post hoc* test at 1.0 s                                                    *p* = 0.04
  ak     [Table 3](#T3){ref-type="table"}                    Two-tailed Mann-Whitney *U* test (capacitance)                                           *p* = 0.002
  al     [Table 3](#T3){ref-type="table"}                    Two-tailed Mann-Whitney *U* test (input resistance)                                      *p* = 0.09
  am     [Table 3](#T3){ref-type="table"}                    Two-tailed Mann-Whitney *U* test (resting membrane potential)                            *p* = 0.5
  an     [Table 3](#T3){ref-type="table"}                    Two-tailed Mann-Whitney *U* test (spike amplitude)                                       *p* = 0.8
  ao     [Fig. 4A](#F4){ref-type="fig"}                      Two-tailed unpaired *t* test                                                             *p* = 0.009
  ap     [Fig. 4B](#F4){ref-type="fig"}                      Two-way repeated-measures ANOVA (current injected × treatment)                           *F*~(10,1930)~ = 4.7; *p* \< 0.0001
  aq     [Fig. 4B](#F4){ref-type="fig"} (rising phase)       Two-way repeated-measures ANOVA (current injected)                                       *F*~(3,579)~ = 922.1; *p* \< 0.0001
  ar     [Fig. 4B](#F4){ref-type="fig"} (rising phase)       Two-way repeated-measures ANOVA (treatment)                                              *F*~(1,193)~ = 4.9; *p* = 0.03
  as     [Fig. 4B](#F4){ref-type="fig"} (rising phase)       Two-way repeated-measures ANOVA (current injected × treatment)                           *F*~(3,579)~ = 2.3; *p* = 0.07
  at     [Fig. 4B](#F4){ref-type="fig"} (descending phase)   Two-way repeated-measures ANOVA (current injected)                                       *F*~(3,579)~ = 144.3; *p* \< 0.0001
  au     [Fig. 4B](#F4){ref-type="fig"} (descending phase)   Two-way repeated-measures ANOVA (treatment)                                              *F*~(1,193)~ = 4.2, *p* = 0.04
  av     [Fig. 4B](#F4){ref-type="fig"} (descending phase)   Two-way repeated-measures ANOVA (current injected × treatment)                           *F*~(3,579)~ = 0.3; *p* = 0.8
  aw     [Fig. 4D](#F4){ref-type="fig"}                      Two-way repeated-measures ANOVA on log-transformed data (current injected)               *F*~(1,174)~ = 56.4; *p* \< 0.0001
  ax     [Fig. 4D](#F4){ref-type="fig"}                      Two-way repeated-measures ANOVA on log-transformed data (treatment)                      *F*~(1,174)~ = 5.2; *p* = 0.02
  ay     [Fig. 4D](#F4){ref-type="fig"}                      Two-way repeated-measures ANOVA on log-transformed data (current injected × treatment)   *F*~(1,174)~ = 0.04; *p* = 0.8
  az     [Fig. 4D](#F4){ref-type="fig"}                      Two-tailed Mann-Whitney *U* test (at 100 pA)                                             *p* = 0.03
  ba     [Fig. 4D](#F4){ref-type="fig"}                      Two-tailed Mann-Whitney *U* test (at 250 pA)                                             *p* = 0.04
  bb     [Fig. 5A](#F5){ref-type="fig"}                      Two-tailed unpaired *t* test                                                             *p* = 0.01
  bc     [Fig. 5B](#F5){ref-type="fig"}                      Two-tailed Mann-Whitney *U* test                                                         *p* = 0.008
  bd     [Fig. 5C1](#F5){ref-type="fig"}                     Two-way repeated-measures ANOVA (time)                                                   *F*~(11,1419)~ = 30.5; *p* \< 0.0001
  be     [Fig. 5C1](#F5){ref-type="fig"}                     Two-way repeated-measures ANOVA (treatment)                                              *F*~(1,1419)~ = 35.8; *p* \< 0.0001
  bf     [Fig. 5C2](#F5){ref-type="fig"}                     Two-tailed unpaired *t* test                                                             *p* = 0.01
  bg     [Fig. 5C3](#F5){ref-type="fig"}                     Two-tailed Mann-Whitney *U* test                                                         *p* = 0.01
  bh     [Table 4](#T4){ref-type="table"}                    Two-tailed Mann-Whitney *U* test (frequency)                                             *p* = 0.6
  bi     [Table 4](#T4){ref-type="table"}                    Two-tailed Mann-Whitney *U* test (amplitude)                                             *p* = 0.08
  bj     [Table 4](#T4){ref-type="table"}                    Two-tailed Mann-Whitney *U* test (10--90 rise)                                           *p* = 0.0008
  bk     [Table 4](#T4){ref-type="table"}                    Two-tailed Mann-Whitney *U* test (10--90 slope)                                          *p* = 0.02
  bl     [Table 4](#T4){ref-type="table"}                    Two-tailed Mann-Whitney *U* test (decay)                                                 *p* = 0.9
  bm     [Fig. 7A](#F7){ref-type="fig"}                      Two-tailed Mann-Whitney *U* test                                                         *p* = 0.1
  bn     [Fig. 7B](#F7){ref-type="fig"}                      Two-tailed unpaired *t* test                                                             *p* = 0.04
  bo     [Fig. 7C1](#F7){ref-type="fig"}                     Two-way repeated-measures ANOVA (time)                                                   *F~(11,311)~ = 4.0*; *p \< 0.0001*
  bp     [Fig. 7C1](#F7){ref-type="fig"}                     Two-way repeated-measures ANOVA (treatment)                                              *F~(1,311)~ = 5.4*; *p = 0.02*
  bq     [Fig. 7C2](#F7){ref-type="fig"}                     Two-tailed unpaired *t* test                                                             *p* = 0.6
  br     [Fig. 7C3](#F7){ref-type="fig"}                     Two-tailed unpaired *t* test                                                             *p* = 0.047
  bs     [Table 5](#T5){ref-type="table"}                    Two-tailed Pearson correlation coefficient                                               As indicated
  bt     [Table 6](#T6){ref-type="table"}                    Two-tailed Pearson correlation coefficient                                               As indicated

Results {#s4}
=======

The objective of this study was to determine long-term consequences of developmental binge-pattern ethanol exposure on performance in an attention task and on the function of mPFC layer VI pyramidal neurons that support attention processing. Developing mice were administered ethanol or isocaloric/isovolumetric sucrose control from G10 to G18 and P4 to P14. Attention performance was measured in adulthood using the 5-CSRTT, and the function of mPFC layer VI neurons from these same mice was assessed using whole-cell electrophysiology in acute brain slices. Refer to [Figure 1](#F1){ref-type="fig"} for a schematic of the study design. BEC of pregnant mice 1 h after the second daily administration of ethanol on G15 was 234.8 ± 34.2 mg/dl (*n* = 9). The BEC of mice from three separate litters that were administered ethanol from P4 to P10 (and not included in the remainder of this study) 1 h after the second daily administration of ethanol on P10 was 255.2 ± 43 mg/dl (*n* = 14). These BEC values are similar to those found in previous studies following binge-pattern oral administration of ethanol to developing mice ([@B41]; [@B20]; [@B42]), rats ([@B51]; [@B87]; [@B11]) and guinea pigs ([@B3]; [@B40]; [@B69]), where neurocognitive and neurological teratogenic effects were observed. It should be noted that these BEC values are also similar to those predicted in a recent ethanol pharmacokinetic modeling study for pregnant mice after a single 4-g/kg oral dose of ethanol ([@B57]). However, the same study found these values to be approximately one-half of those predicted for pregnant humans after the same ethanol dose ([@B57]). There was no effect of ethanol treatment on the amount of food consumed by dams or litters, although there was a small decrease in the amount of food consumed by dams of both groups on the first day of treatment only (data not shown). We observed no effect of treatment on the length of gestation, litter size at P4, or offspring body weight at any point during postnatal development (all reported in [Table 2](#T2){ref-type="table"}).

![Schematic illustration of the study design. Timed-pregnant female mice were administered either ethanol or an isocaloric/isovolumetric amount of sucrose by gavage from G10 to G18. Offspring were then administered the same treatment (ethanol or sucrose) by gavage from P4 to P14. Male offspring were food-restricted and tested for attention behavior using the 5-CSRTT from P60 to P193 (the age of the oldest mouse to complete testing). The same cohort of male offspring was then tested for electrophysiological function of medial prefrontal layer VI pyramidal neurons between P225 and P273. The coronal slice diagram was modified from [@B76]. Timelines are not drawn to scale.](enu0051621710001){#F1}

###### 

Pregnancy outcome and offspring body weight.

  Characteristic                       Sucrose      Ethanol      *p*-value
  ------------------------------------ ------------ ------------ -----------
  Number of litters                    8            9            
  Gestation length (d)                 19.9 ± 0.1   20.3 ± 0.2   0.3^a^
  Litter size (number of pups at P4)   8.4 ± 0.9    8.2 ± 0.6    0.9^b^
  Offspring body weight (g)                                      
      P4 (female and male)             2.8 ± 0.1    2.9 ± 0.1    1.0^c^
      P14 (female and male)            7.1 ± 0.2    6.9 ± 0.1    1.0^c^
      P21 (male only)                  9.8 ± 0.6    9.6 ± 0.2    1.0^c^
      P28 (male only)                  16.5 ± 0.9   16.7 ± 0.3   1.0^c^
      P60 (male only)                  24.6 ± 0.8   24.7 ± 0.2   1.0^c^

Data are presented as litter mean ± 1 SEM. Data sets were analyzed by ^a^Mann--Whitney *U* test, ^b^two-tailed unpaired *t* test, or ^c^Bonferroni's *post hoc* test.

Developmental ethanol exposure impairs performance on an attention task in adulthood {#s4A}
------------------------------------------------------------------------------------

We first sought to measure performance of adult offspring on the 5-CSRTT ([@B84]), because deficits in attention make up one of the most common and persistent neurobehavioral consequences of prenatal ethanol exposure in humans ([@B9]; [@B30]). Thirty-two young adult male mice (*n* = 16 for each developmental treatment group sampled randomly from eight sucrose-treated litters and nine ethanol-treated litters) were trained to detect and respond to an illuminating light stimulus presented randomly in one of five locations, to receive a reinforcing food reward. Training on the 5-CSRTT began with a stimulus duration of 8 s, and this was decreased in successive steps to increase attentional demand until the final stimulus duration of 1 s was reached. Mice were required to meet the criteria of 60 trials completed within 60 min with \>80% accuracy and \<20% omissions on three of four consecutive daily sessions to advance to the next stimulus duration. A full description of the training procedure is presented in Materials and Methods. One mouse in the sucrose treatment group stopped performing the task during this behavioral testing and was removed from all analyses.

The number of days (sessions) required to reach criteria at each stimulus duration was significantly affected by stimulus duration, where mice required the greatest number of days both during initial training on the task (8 s) and also at the shorter stimulus durations (1.2 and 1.0 s) that involve greater attentional demand ([Fig. 2*A*](#F2){ref-type="fig"}, two-way repeated-measures ANOVA, effect of stimulus duration, *F*~(7,203)~ = 13.2; *p* \< 0.0001). Mice from the ethanol treatment group required more days to reach criteria than mice in the sucrose treatment group (effect of developmental treatment, *F*~(1,29)~ = 6.9; *p* = 0.01), and this effect of treatment was most pronounced at both the initial 8 s (Bonferroni's *post hoc* test, *p* = 0.04) and the shortest 1 s (*p* \<0.0001) stimulus durations. The remainder of data in [Fig. 2](#F2){ref-type="fig"} are presented as means for all days up to and including the day when each mouse met criteria for each stimulus duration. Mice in the ethanol treatment group required more time to complete 60 trials than mice in the sucrose treatment group at 8 s only ([Fig. 2*B*](#F2){ref-type="fig"}; effect of stimulus duration, *F*~(7,203)~ = 178.2; *p* \< 0.0001; effect of developmental treatment, *F*~(1,29)~ = 2.3; *p* = 0.1; effect of interaction, *F*~(7,203)~ = 5.3; *p* \< 0.0001, Bonferroni's *post hoc* test at 8 s, *p* \<0.0001). Mice responded with the lowest accuracy percentage at 8 s ([Fig. 2*C*](#F2){ref-type="fig"}; effect of stimulus duration, *F*~(7,203)~ = 26.7, *p* \< 0.0001), whereas mice in the ethanol treatment group showed a lower percent accuracy than mice in the sucrose treatment group (main effect of developmental treatment, *F*~(1,29)~ = 0.2; *p* = 0.6; effect of interaction, *F*~(7,203)~ = 2.8; *p* = 0.009, Bonferroni's *post hoc* test at 8 s, *p* = 0.005). As shown in [Figure 2*D*](#F2){ref-type="fig"}, the percentage of omissions (no response) increased as stimulus duration decreased (effect of stimulus duration, *F*~(7,203)~ = 38.4; *p* \< 0.0001), and this effect was most pronounced in mice from the ethanol treatment group, as they showed greater percentages of omissions than mice in the sucrose treatment group at 1.2 and 1.0 s (effect of developmental treatment, *F*~(1,29)~ = 7.1; *p* = 0.01; effect of interaction, *F*~(7,203)~ = 3.2; *p* = 0.003, Bonferroni's *post hoc* test at 1.2 s, *p* = 0.04, and at 1.0 s, *p* \< 0.0001). The number of premature responses per session was greatest at 8 s ([Fig. 2*E*](#F2){ref-type="fig"}; effect of stimulus duration, *F*~(7,203)~ = 58.6; *p* \< 0.0001) but was not affected by treatment (*F*~(1,29)~ = 0.8; *p* = 0.4). Similarly, as shown in [Figure 2*F*](#F1){ref-type="fig"}, correct response latency was affected by stimulus duration (*F*~(7,203)~ = 430.1; *p* \< 0.0001) but not by treatment (*F*~(1,29)~ = 0.01; *p* = 0.9). The number of responses per session that were perseverative to the correct response was not affected by stimulus duration (data not shown; *F*~(7,203)~ = 1.1; *p* = 0.3) or developmental treatment (*F*~(1,29)~ = 2.5; *p* = 0.1). Reward collection latency was greatest at 8 s compared with the other stimulus durations (data not shown; effect of stimulus duration, *F*~(7,203)~ = 12.7; *p* \< 0.0001) but was not affected by developmental treatment (*F*~(1,29)~ = 0.03; *p* = 0.9).

![Developmental ethanol exposure impairs performance on an attention task in adulthood. Adult male offspring were trained on the 5-CSRTT for visual attention. Training began with the light stimulus duration set to 8 s, and each mouse was required to achieve the criteria of (i) 60 trials completed in 60 min, (ii) \>80% accuracy, and (iii) \<20% omissions for three of four consecutive days to advance to the next-lowest stimulus duration. The number of days required to meet criteria at each stimulus duration is shown in ***A***, where the dotted line represents the minimum of 3 days. Mice that were administered ethanol during development required more days to reach criteria than mice that were administered sucrose during development, both during initial training on the task and also at the lowest stimulus duration that required the highest attentional demand (two-way repeated-measures ANOVA, effect of developmental treatment, *p* = 0.01; effect of stimulus duration, *p* \< 0.0001; interaction, *p* = 0.001; Bonferroni's *post hoc* test at 8 s, \**p* = 0.04, and at 1 s, ^§^*p* \< 0.0001). All remaining data are shown as the mean performance for all days up to and including the day on which each mouse met training criteria for each stimulus duration. ***B***, Mice that were administered ethanol during development required more time to complete 60 trials at the initial 8-s stimulus duration (effect of developmental treatment, *p* = 0.1; effect of stimulus duration, *p* \< 0.0001; interaction, *p* \< 0.0001; Bonferroni's *post hoc* test at 8 s, ^§^*p* \< 0.0001). Mice that were administered ethanol showed lower accuracy at the initial 8-s stimulus duration (***C***, effect of developmental treatment, *p* = 0.6; effect of stimulus duration, *p* \< 0.0001; interaction, *p* = 0.009; Bonferroni's *post hoc* test at 8 s, ^‡^*p* = 0.005), and also showed greater omissions, which was most pronounced at lower stimulus durations (***D***, effect of developmental treatment, *p* = 0.01; effect of stimulus duration, *p* \< 0.0001; interaction, *p* = 0.003; Bonferroni's *post hoc* test at 1.2 s, \**p* = 0.04, and at 1 s, ^§^*p* \< 0.0001). ***E***, The number of premature responses per session was affected by stimulus duration (*p* \< 0.0001) but not by developmental treatment (*p* = 0.4). ***F***, The latency to make correct responses also was affected by stimulus duration (*p* \< 0.0001) but not by developmental treatment (*p* = 0.9). All data are shown as mean + 1 SEM.](enu0051621710002){#F2}

Mice from the ethanol treatment group continued to show impaired performance on the 5-CSRTT even when they were considered to be fully trained. We next analyzed data only for the 3 days on which each mouse met training criteria for each stimulus duration. The time required to complete 60 trials was affected by stimulus duration ([Fig. 3*A*](#F3){ref-type="fig"}; two-way repeated-measures ANOVA, *F*~(7,203)~ = 73.1; *p* \< 0.0001), and although there was no main effect of developmental treatment (*F*~(1,29)~ = 1.3; *p* = 0.3), there was a significant interaction between effects (*F*~(7,203)~ = 2.5; *p* = 0.02) and mice from the ethanol treatment group requiring more time to complete 60 trials at 8 s than mice in the sucrose treatment group (Bonferroni's *post hoc* test, *p* = 0.001). As shown in [Figure 3*B*](#F3){ref-type="fig"} for the percentage of omissions, it is most interesting that effects of stimulus duration (*F*~(7,203)~ = 42.8; *p* \< 0.0001) and developmental treatment (*F*~(1,29)~ = 5.6; *p* = 0.03, Bonferroni's *post hoc* test at 1.6 s, *p* = 0.02, and at 1.0 s, *p* = 0.04) persisted in mice that were fully trained on the task. The same analysis for the other measures within the 5-CSRTT did not show effects of developmental treatment in the trained mice (data not shown). Accuracy (*F*~(7,203)~ = 3.7; *p* = 0009), premature responding (*F*~(7,\ 203)~ = 22.0; *p* \< 0.0001), correct response latency (*F*~(7,\ 203)~ = 250.2; *p* \< 0.0001), and reward collection latency (*F*~(7,\ 203)~ = 8.1; *p* \< 0.0001) were all affected by stimulus duration but not by developmental treatment (all *p* \> 0.05). The number of responses that were perseverative to the correct response was not affected by stimulus duration or developmental treatment (both *p* \> 0.05).

![Developmental ethanol exposure impairs performance on the 5-CSRTT even when mice are considered to be trained. Data are shown as means for the 3 days on which each mouse met the training criteria for each stimulus duration. ***A***, Mice that were administered ethanol during development required more time to complete 60 trials at the 8-s stimulus duration than mice that were administered sucrose during development (two-way repeated-measures ANOVA; effect of developmental treatment, *p* = 0.3; effect of stimulus duration, *p* \< 0.0001; interaction, *p* = 0.01; Bonferroni's *post hoc* test at 8 s, ^‡^*p* = 0.001). ***B***, Mice that were administered ethanol during development committed more errors of omission when trained on the task, and this effect was most prominent at lower stimulus durations that required higher attentional demand (effect of developmental treatment, *p* = 0.03; effect of stimulus duration, *p* \< 0.0001; interaction, *p* = 0.04; Bonferroni's *post hoc* test at 1.6 s, \**p* = 0.02, and at 1 s, \**p* = 0.04). All data are shown as mean + 1 SEM.](enu0051621710003){#F3}

Developmental ethanol exposure decreases the intrinsic excitability of prefrontal layer VI pyramidal neurons {#s4B}
------------------------------------------------------------------------------------------------------------

We next sought to determine whether developmental binge-pattern ethanol exposure influences the function of adult mPFC layer VI pyramidal neurons, because approximately 40% of neurons in this population provide feedback from the mPFC to the thalamus ([@B31]; [@B95]) and ACh neurotransmission via their α4β2\* nAChRs is necessary for proper attention performance ([@B5]; [@B32]). We prepared acute brain slices from the same mice that had been tested on the 5-CSRTT and first measured the basic passive and active electrophysiological properties of layer VI neurons. The brain from one mouse in the sucrose treatment group was lost to a technical issue, leaving 14 mice in the sucrose treatment group and 16 mice in the ethanol treatment group for experiments. Data and statistical analysis of basic electrophysiological properties are shown in [Table 3](#T3){ref-type="table"}. Neurons from mice in the ethanol treatment group showed significantly lower capacitance (Mann--Whitney *U* test, *p* = 0.002) and a trend toward higher input resistance (*p* = 0.09) compared with neurons from mice in the sucrose treatment group. There was no effect of developmental treatment on resting membrane potential or spike amplitude (both *p* \> 0.05).

###### 

Basic electrophysiological properties of prefrontal layer VI pyramidal neurons.

  Characteristic                    Sucrose        Ethanol        *p*-value
  --------------------------------- -------------- -------------- -----------
  Number of mice                    14             16             
  Number of neurons                 104            114            
  Capacitance (pF)                  56.9 ± 0.9     53.4 ± 0.9     0.002\*
  Input resistance (MΩ)             228.7 ± 7.5    240.6 ± 7.8    0.09
  Resting membrane potential (mV)   --78.7 ± 0.5   --78.3 ± 0.4   0.5
  Spike amplitude (mV)              95.0 ± 0.5     94.7 ± 0.5     0.8

Data are presented as mean ± 1 SEM for neurons within each data set. Data sets were analyzed by Mann--Whitney *U* test. \*Statistically significant (*p* \< 0.05).

Measures of intrinsic excitability for mPFC layer VI pyramidal neurons are shown in [Figure 4](#F4){ref-type="fig"}. The amount of positive current injection required to reach action potential threshold from rest (rheobase) was significantly greater in neurons from mice in the ethanol treatment group (78.9 ± 3.9 pA, *n* = 90) than in neurons from mice in the sucrose treatment group (66.0 ± 3.1 pA, *n* = 106; [Fig. 4*A*](#F4){ref-type="fig"}, two-tailed unpaired *t* test, *p* = 0.009). The excitability of neurons from mice in the ethanol treatment group was also lower at this range of positive current input, as shown by the input/output curve in [Figure 4*B*](#F4){ref-type="fig"}. Here, the relationship between the amount of current injected over 500 ms and the resulting action potential frequency was shifted to the right for neurons from mice in the ethanol group compared with neurons from mice in the sucrose treatment group (two-way repeated-measures ANOVA for all data, interaction between effects of current and developmental treatment, *F*~(10,1930)~ = 4.7; *p* \< 0.0001). Firing frequency was lower in neurons from mice in the ethanol treatment group on the rising phase of the input/output curve between 50 and 200 pA (two-way repeated-measures ANOVA, effect of current, *F*~(3,579)~ = 922.1; *p* \< 0.0001; effect of developmental treatment, *F*~(1,193)~ = 4.9; *p* = 0.03; interaction between effects, *F*~(3,579)~ = 2.3; *p* = 0.07), and firing frequency was greater in neurons from the ethanol treatment group on the descending phase of the input/output curve between 350 and 500 pA (effect of current, *F*~(3,579)~ = 144.3; *p* \< 0.0001; effect of developmental treatment, *F*~(1,193)~ = 4.2, *p* = 0.04; interaction between effects, *F*~(3,579)~ = 0.3; *p* = 0.8). Given the influence of developmental ethanol exposure on neuron excitability, we next analyzed effects of treatment on neuron afterhyperpolarization (AHP) by measuring the peak AHP after the end of the action potential trains generated in the input/output experiment. This measurement was performed at the 100-pA injection, where we observed an effect of developmental treatment on firing frequency (e.g., as shown in [Fig. 4*C*](#F4){ref-type="fig"}) and at the 250-pA injection, where firing frequency was similar between treatment groups. As shown in [Figure 4*D*](#F4){ref-type="fig"}, the peak AHP amplitude was greater in neurons from mice in the ethanol treatment group than in neurons from mice in the sucrose treatment group at both levels of current injection (two-way repeated-measures ANOVA on log-transformed data; effect of current, *F*~(1,174)~ = 56.4; *p* \< 0.0001; effect of developmental treatment, *F*~(1,174)~ = 5.2; *p* = 0.02; interaction between effects, *F*~(1,174)~ = 0.04; *p* = 0.8; Mann-Whitney *U* test on raw data at each level of current injection, *p* \< 0.04). AHP amplitudes after 100-pA current injection were 1.1 ± 0.1 mV (*n* = 92) for neurons in the sucrose treatment group and 1.4 ± 0.1 mV (*n* = 84) for neurons in the ethanol treatment group, and AHP amplitudes after 250-pA current injection were 1.4 ± 0.1 mV (*n* = 92) for neurons in the sucrose treatment group and 1.7 ± 0.1 mV (*n* = 84) for neurons in the ethanol treatment group.

![Developmental ethanol exposure decreases the intrinsic excitability of adult medial prefrontal layer VI pyramidal neurons. ***A***, Neurons from mice that were administered ethanol during development required more current to reach action potential threshold from rest (rheobase) than neurons from mice that were administered sucrose during development (two-tailed unpaired *t* test, \**p* = 0.009). ***B***, The input--output curve is shifted to the right in neurons from mice that were administered ethanol during development (two-way repeated-measures ANOVA; interaction between effects of current and developmental treatment, *p* \< 0.0001; effect of developmental treatment within each indicated segment, \**p* \< 0.04). Representative action potential trains elicited by 100-pA current steps are shown in ***C*** for one neuron from each developmental treatment group. ***D***, AHP amplitude at the end of the action potential trains elicited by 100- and 250-pA current steps is greater in neurons from mice that were administered ethanol during development (two-way repeated-measures ANOVA on log-transformed data, *p* = 0.02; Mann--Whitney *U* test on raw data for each current step, *p* \< 0.04). Representative AHP traces are shown on the right for one neuron from each developmental treatment group. All data are shown as mean ± 1 SEM.](enu0051621710004){#F4}

Developmental ethanol exposure increases the response to nicotinic receptor stimulation in prefrontal layer VI pyramidal neurons {#s4C}
--------------------------------------------------------------------------------------------------------------------------------

Given the importance of cholinergic signaling within the mPFC ([@B75]; [@B21]; [@B72]), and specifically at α4β2\* nAChRs on mPFC layer VI pyramidal neurons ([@B32]), for normal performance in attention tasks, we next sought to measure effects of developmental ethanol exposure on nAChR function. Whole-cell current responses were measured after the application of 1 m[m]{.smallcaps} ACh for 15 s in the presence of 200 n[m]{.smallcaps} atropine (to block muscarinic receptors). Such nicotinic responses are mediated in these neurons by α4β2\* nAChRs ([@B43]; [@B5]; [@B79]; [@B10]). As shown in [Figure 5*A*](#F5){ref-type="fig"}, nAChR current responses were significantly greater in neurons from mice in the ethanol treatment group (48.5 ± 2.7 pA, *n* = 62) than in neurons from mice in the sucrose treatment group (38.9 ± 2.6 pA, *n* = 58; two-tailed unpaired *t* test, *p* = 0.01). Nicotinic responses were next assessed in active neurons by injecting positive current to induce action potential firing at approximately 1 Hz, and then measuring the increase in firing rate in response to the application of 1 m[m]{.smallcaps} ACh for 15 s in the presence of 200 n[m]{.smallcaps} atropine. Here, the percent by which firing increased over baseline for each neuron was also greater in neurons from mice in the ethanol treatment group (425 ± 21%, *n* = 63) than in neurons from mice in the sucrose treatment group (352 ± 21%, *n* = 58; [Fig. 5*B*](#F5){ref-type="fig"}, Mann--Whitney *U* test, *p* = 0.008). The magnitude and kinetics for instantaneous firing frequency in this experiment were also affected by developmental treatment ([Fig. 5*C*](#F5){ref-type="fig"}). Firing frequency was greater during the ACh response period for neurons from mice in the ethanol treatment group (Fig. [5](#F5){ref-type="fig"}*C1* ; two-way ANOVA; effect of time, *F*~(11,1419)~ = 30.5; *p* \< 0.0001; effect of developmental treatment, *F*~(1,1419)~ = 35.8; *p* \< 0.0001). The peak firing frequency for each neuron was greater in neurons from mice in the ethanol treatment group (3.7 ± 0.2 Hz, *n* = 63) than in neurons from mice in the sucrose treatment group (2.9 ± 0.2 Hz, *n* = 58; Fig. [5](#F5){ref-type="fig"}*C2* ; two-tailed unpaired *t* test, *p* = 0.01). In addition, this peak ACh response occurred at an earlier time in neurons from mice in the ethanol treatment group (77.0 ± 2.4 s, *n* = 63) than in neurons from mice in the sucrose treatment group (81.5 ± 2.3 s, *n* = 58; Fig. [5](#F5){ref-type="fig"}*C3* ; Mann--Whitney *U* test, *p* = 0.01).

![Developmental ethanol exposure increases nicotinic receptor function in adult medial prefrontal layer VI pyramidal neurons. ***A***, The peak inward current response to 1 m[m]{.smallcaps} acetylcholine (15 s in the presence of 200 n[m]{.smallcaps} atropine) was significantly greater in neurons from mice that were administered ethanol during development than in neurons from mice that were administered sucrose during development (two-tailed unpaired *t* test, \**p* = 0.01). Exemplary voltage-clamp traces are shown on the right for one neuron from each developmental treatment group. ***B***, For neurons that had been induced to fire action potentials by current injection, further nicotinic stimulation with 1 m[m]{.smallcaps} acetylcholine (15 s in the presence of 200 n[m]{.smallcaps} atropine) increased firing frequency to a greater degree in neurons from mice that were administered ethanol during development (Mann--Whitney *U* test, ^‡^*p* = 0.008). Exemplary current-clamp traces are shown on the right for one neuron from each developmental treatment group. The instantaneous firing frequency for this experiment is plotted against time in **C1**, where a significant effect of developmental treatment was observed during the acetylcholine response period (two-way ANOVA, ^§^*p* \< 0.0001). Firing frequency peaked at a greater magnitude (**C2**, Mann--Whitney *U* test, \**p* = 0.01) and occurred at an earlier time (**C3**, two-tailed unpaired *t* test, \**p* = 0.01) in neurons from mice that were administered ethanol during development. Acetylcholine applications are indicated on all traces by a gray bar. All data are shown as mean ± 1 SEM.](enu0051621710005){#F5}

We also measured muscarinic ACh receptor (mAChR) function in the same mice and found no effect of developmental ethanol exposure. Whole-cell inward current responses after the application of 1 m[m]{.smallcaps} ACh for 15 s (in the presence of 3 μ[m]{.smallcaps} DHβE to block α4β2\* nAChRs; these neurons are not activated by α7 nAChRs) were 6.0 ± 0.7 pA (*n* = 28) for neurons from mice in the sucrose treatment group and 6.8 ± 0.4 pA (*n* = 35) for neurons from mice in the ethanol treatment group (two-tailed unpaired *t* test, *p* = 0.3). Muscarinic responses in active neurons were assessed by injecting positive current to induce action potential firing at approximately 1 Hz and then measuring the increase in firing rate in response to the application of 1 m[m]{.smallcaps} ACh for 15 s in the presence of 3 μ[m]{.smallcaps} DHβE. The percentage increase in firing rate was not different between neurons from mice in the sucrose treatment group (328 ± 20%, *n* = 28) and neurons from mice in the ethanol treatment group (359 ± 22%, *n* = 35; Mann--Whitney *U* test, *p* = 0.5).

Developmental ethanol exposure increases the response to AMPA receptor stimulation in prefrontal layer VI pyramidal neurons {#s4D}
---------------------------------------------------------------------------------------------------------------------------

In performing the ACh experiments described above, we observed differences between experimental groups for the magnitude and kinetics of sEPSCs in mPFC layer VI pyramidal neurons. Spontaneous EPSCs were measured in voltage clamp mode for neurons held at --75 mV, which is near the measured equilibrium potential for chloride in our preparation of --73.5 mV. This nonpharmacological approach thus mitigates any influence of GABA~A~ receptor signaling and also is below the voltage threshold for NMDA glutamatergic receptor activation. Moreover, all sEPSCs in this preparation are blocked by the AMPA/kainate glutamatergic receptor competitive antagonist CNQX (data not shown). Data and statistical analyses for all neurons in this study are shown in [Table 4](#T4){ref-type="table"}. There was no effect of developmental treatment on the frequency of sEPSCs (Mann--Whitney *U* test, *p* = 0.6), although there was a trend toward a greater amplitude of sEPSCs in neurons from mice in the ethanol treatment group (*p* = 0.08). The onset kinetics for sEPSCs were significantly affected by developmental treatment, as the sEPSC rise time was shorter (*p* = 0.0008) and rise slope was greater (*p* = 0.02) in neurons from mice in the ethanol treatment group than in neurons from mice in the sucrose treatment group. The sEPSC decay time was not affected by developmental treatment (*p* = 0.9). Exemplar and average traces of recorded sEPSCs from neurons of each developmental treatment group are shown in [Figure 6](#F6){ref-type="fig"}.

###### 

Properties of sEPSCs in prefrontal layer VI pyramidal neurons.

  Characteristic         Sucrose       Ethanol       *p*-value
  ---------------------- ------------- ------------- -----------
  Number of mice         14            16            
  Number of neurons      98            104           
  Frequency (Hz)         0.65 ± 0.06   0.68 ± 0.05   0.6
  Amplitude (pA)         11.4 ± 0.3    12.4 ± 0.4    0.08
  10--90 Rise (ms)       2.7 ± 0.1     2.3 ± 0.1     0.0008\*
  10--90 Slope (pA/ms)   --5.5 ± 0.3   --7.2 ± 0.5   0.02\*
  Decay (ms)             4.9 ± 0.2     5.0 ± 0.2     0.9

Data are presented as mean ± 1 SEM for neurons within each data set. Data sets were analyzed by Mann--Whitney *U* test. \*Statistically significant (*p* \< 0.05).

![Exemplary traces of recorded glutamatergic sEPSCs. ***A***, Exemplary traces are shown for one neuron from the sucrose (**A1**) and ethanol (**A2**) developmental treatment groups held at --75 mV in voltage-clamp mode. For each neuron, traces of approximately 10 s in length are shown at the top, and four individual exemplary sEPSCs are shown at the bottom. ***B***, The average of 200 representative EPSC traces is shown for neurons from the sucrose (blue) and ethanol (red) developmental treatment groups. Data for the frequency, amplitude, and kinetics of sEPSCs in this study are shown in Table 4.](enu0051621710006){#F6}

Given the observed effects of developmental binge-pattern ethanol exposure on AMPA/kainate-mediated EPSCs and the importance of glutamatergic signaling within the mPFC for attention ([@B63]; [@B81]; [@B73]; [@B38]), we next measured AMPA receptor function directly in mPFC layer VI pyramidal neurons. Experiments were performed on a subset of mice from study (ethanol, *n* = 6; sucrose, *n* = 9). We first measured whole-cell current responses after 15-s application of 2 μ[m]{.smallcaps} (S)-AMPA and found the difference between treatment group means to be similar in magnitude to that for nicotinic currents \[[Fig. 7*A*](#F7){ref-type="fig"}; ethanol: 45.5 ± 7.4 pA (*n* = 12); sucrose: 34.2 ± 4.7 pA (*n* = 17)\], although this difference was not significant (Mann--Whitney *U* test, *p* = 0.1). Excitatory responses to AMPA were next assessed in active neurons by injecting positive current to induce action potential firing at approximately 1 Hz, and then measuring the increase in firing rate after 15-s application of 2 μ[m]{.smallcaps} (S)-AMPA. The percentage by which firing increased over baseline for each neuron was significantly greater in neurons from mice in the ethanol treatment group (365 ± 48%, *n* = 12) than in neurons from mice in the sucrose treatment group (270 ± 15%, *n* = 16; [Fig. 7*B*](#F7){ref-type="fig"}; two-tailed unpaired *t* test, *p* = 0.04). The timing for AMPA responses in this experiment was also affected by developmental treatment ([Fig. 7*C*](#F7){ref-type="fig"}). Firing frequency was greater during the AMPA response period for neurons from mice in the ethanol treatment group (Fig. [7](#F7){ref-type="fig"}*C1* ; two-way ANOVA; effect of time, *F*~(11,311)~ = 4.0; *p* \< 0.0001; effect of developmental treatment, *F*~(1,311)~ = 5.4; *p* = 0.02). The peak firing frequency for each neuron was not significant between neurons from mice in the ethanol treatment group (3.3 ± 0.2 Hz, *n* = 12) and neurons from mice in the sucrose treatment group (3.0 ± 0.4 Hz, *n* = 16; Fig. [7](#F7){ref-type="fig"}*C2* ; two-tailed unpaired *t* test, *p* = 0.6). However, the peak response to AMPA occurred at an earlier time in neurons from mice in the ethanol treatment group (79.8 ± 4.9 s, *n* = 12) than in neurons from mice in the sucrose treatment group (96.1 ± 5.7 s, *n* = 16; Fig. [7](#F7){ref-type="fig"}*C3* ; *p* = 0.047).

![Developmental ethanol exposure increases AMPA receptor function in adult medial prefrontal layer VI pyramidal neurons. ***A***, The peak inward current response to 2 μ[m]{.smallcaps} (S)-AMPA (15 s) was not significantly different between neurons from mice that were administered ethanol during development and neurons from mice that were administered sucrose during development (Mann--Whitney *U* test, *p* = 0.1). Exemplary voltage-clamp traces are shown on the right for one neuron from each developmental treatment group. ***B***, For neurons that had been induced to fire action potentials by current injection, further glutamatergic stimulation with 2 μ[m]{.smallcaps} (S)-AMPA (15 s) increased firing frequency to a greater degree in neurons from mice that were administered ethanol during development (two-tailed unpaired *t* test, \**p* = 0.04). Exemplary current-clamp traces are shown on the right for one neuron from each developmental treatment group. The instantaneous firing frequency for this experiment is plotted against time in **C1**, where a significant effect of developmental treatment was observed during the (S)-AMPA response period (two-way repeated-measures ANOVA, \**p* = 0.02). The peak firing frequency was not significantly different between developmental treatment groups (**C2**, two-tailed unpaired *t* test, *p* = 0.6) although it did occur at an earlier time in neurons from mice that were administered ethanol during development (**C3**, two-tailed unpaired *t* test, \**p* = 0.047). AMPA applications are indicated on all traces by a gray bar. All data are shown as mean ± 1 SEM.](enu0051621710007){#F7}

Developmental ethanol exposure disrupts the relationship between prefrontal nicotinic receptor function and performance on an attention task {#s4E}
--------------------------------------------------------------------------------------------------------------------------------------------

The analysis of neuron function and performance on the 5-CSRTT within the same experimental animals provided the opportunity to determine whether specific properties of mPFC layer VI pyramidal neurons correlate with attention performance. Neuron electrophysiological properties were compared with two measures of attention processing that were negatively affected by developmental ethanol exposure: (i) accuracy percentage at the 8-s stimulus duration (full correlation data are presented in [Table 5](#T5){ref-type="table"}) and (ii) percentage of omissions at the 1-s stimulus duration (full correlation data are presented in [Table 6](#T6){ref-type="table"}). Mice in the sucrose group showed a positive correlation between nicotinic inward currents (data from [Fig. 5*A*](#F5){ref-type="fig"}) and accuracy percentage (data from [Fig. 2*C*](#F2){ref-type="fig"}; *p* = 0.02), and also a strong trend toward a positive correlation between nicotinic stimulation of firing neurons (data from [Fig. 5*B*](#F5){ref-type="fig"}) and accuracy percentage (data from [Fig. 2*C*](#F2){ref-type="fig"}; *p* = 0.06). This indicates that mice in the sucrose group with greater layer VI neuron α4β2\* nAChR function performed with greater accuracy on the 5-CSRTT task. In contrast, mice in the ethanol group showed no correlation between nicotinic inward currents and accuracy (*p* = 0.4), or between nicotinic simulation of firing neurons and accuracy (*p* = 0.8). Mice in the sucrose group showed a negative correlation between nicotinic inward currents (data from [Fig. 5*A*](#F5){ref-type="fig"}) and omissions (data from [Fig. 2*D*](#F2){ref-type="fig"}; *p* = 0.05), and also a negative correlation between nicotinic stimulation of firing neurons (data from [Fig. 5*B*](#F5){ref-type="fig"}) and omissions (data from [Fig. 2*D*](#F2){ref-type="fig"}; *p* = 0.03). This indicates that mice in the sucrose group with greater layer VI neuron α4β2\* nAChR function performed with fewer omissions on the 5-CSRTT task. In contrast, mice in the ethanol group showed no correlation between nicotinic inward currents and omissions (*p* = 0.9), or between nicotinic stimulation of firing neurons and omissions (*p* = 0.9). There were no additional correlations in this study between any other electrophysiological measure and attention performance, suggesting that observed relationships between mPFC layer VI neuron function and attention performance in the sucrose group were selective to those involving nicotinic signaling.

###### 

Correlation analysis comparing electrophysiological properties of prefrontal layer VI pyramidal neurons and accuracy percentage at the 8-s stimulus duration in the 5-CSRTT.

  Correlation versus accuracy                       Sucrose   Ethanol            
  ------------------------------------------------- --------- --------- -------- ------
  Resting membrane potential                        --0.37    0.19      0.08     0.78
  Capacitance                                       0.28      0.34      --0.09   0.73
  Input resistance                                  --0.41    0.14      --0.01   0.99
  Spike amplitude                                   0.25      0.38      0.29     0.27
  Rheobase                                          0.51      0.06      0.22     0.52
  Receptor-mediated inward currents                                              
      Nicotinic                                     0.61      0.02      0.21     0.43
      Muscarinic                                    0.03      0.92      0.46     0.07
      AMPA glutamatergic                            --0.06    0.87      --0.16   0.77
  Receptor-mediated stimulation of firing neurons                                
      Nicotinic                                     0.51      0.06      0.08     0.78
      Muscarinic                                    0.41      0.17      0.27     0.31
      AMPA glutamatergic                            0.15      0.72      --0.25   0.64

###### 

Correlation analysis comparing electrophysiological properties of prefrontal layer VI pyramidal neurons and percentage of omissions at the 1-s stimulus duration in the 5-CSRTT.

  Correlation versus omissions                      Sucrose   Ethanol            
  ------------------------------------------------- --------- --------- -------- ------
  Resting membrane potential                        0.46      0.09      0.25     0.35
  Capacitance                                       0.31      0.27      0.23     0.40
  Input resistance                                  0.02      0.95      0.25     0.35
  Spike amplitude                                   0.33      0.24      0.33     0.21
  Rheobase                                          --0.17    0.55      --0.01   0.98
  Receptor-mediated inward currents                                              
      Nicotinic                                     --0.52    0.05      0.03     0.93
      Muscarinic                                    0.09      0.77      --0.08   0.78
      AMPA glutamatergic                            0.51      0.16      0.31     0.55
  Receptor-mediated stimulation of firing neurons                                
      Nicotinic                                     --0.58    0.03      0.02     0.93
      Muscarinic                                    --0.28    0.36      0.14     0.62
      AMPA glutamatergic                            0.10      0.81      0.27     0.61

Discussion {#s5}
==========

This study provides novel insight into the long-term consequences of developmental binge-pattern ethanol exposure on prefrontal attention systems. We found that adult mice exposed to ethanol during development showed decreased performance on the 5-CSRTT for visual attention, as they performed with lower accuracy when first learning the task and with a higher rate of omissions under conditions that required the greatest attentional demand. We then measured the function of pyramidal neurons located within mPFC layer VI of these same experimental animals because cholinergic excitation of this neuronal population is necessary for normal attention performance ([@B21]; [@B72]; [@B32]), these neurons are strongly excited by nAChRs to support attention ([@B43]; [@B5]; [@B32]), and developmental ethanol exposure likely alters the function of nAChRs within cognitive systems ([@B65]). Here, we found that developmental ethanol exposure dysregulated layer VI pyramidal neurons by decreasing intrinsic excitability and increasing responses to stimulation of both α4β2\* nAChRs and AMPA glutamate receptors. These effects were observed approximately 8 months after ethanol exposure, demonstrating the persistence of ethanol's influence on developing prefrontal circuitry. The developmental ethanol exposure paradigm in this study modeled a binge pattern of administration characterized by daily oral ethanol doses that achieved relatively high BEC values, as opposed to alternative approaches that provide sustained access to ethanol in drinking water or liquid diet that typically result in lower BEC values. Self-reported survey data from North America suggests that 25--42% of women drink alcohol during the first trimester, including 8--20% who binge drink, and that 8% of women drink alcohol in the third trimester, including 1% who binge drink ([@B26]; [@B2]). In humans ([@B59]; [@B28]) and rodents ([@B93]), the degree of teratogenic damage to the brain is greater after binge ethanol consumption (higher BEC) than after mild to moderate ethanol consumption (lower BEC), so it will be important in future work to compare the mPFC data from this study with that following a nonbinge pattern of developmental ethanol exposure.

Developmental ethanol exposure and attention {#s5A}
--------------------------------------------

Mice from the ethanol treatment group required more days to meet training criteria on the 5-CSRTT at the initial 8-s stimulus duration because they performed with lower accuracy. Indeed, although mice from the sucrose treatment group performed with an average of 82.1 ± 1.8% accuracy across all training days at 8 s, the average value of 75.6 ± 2.0% for mice in the ethanol treatment group falls below required criterion cutoff of 80%. Although reduced accuracy on the 5-CSRTT is considered to indicate impaired attention ([@B84]), it is also possible that impaired learning contributed to this result, because this was the first opportunity for mice to perform the full version of the task. In support of this learning hypothesis, note that mice from both treatment groups required more time to complete 60 trials, committed more premature responses, and performed with a longer correct response latency at the 8-s stimulus duration than at subsequent stimulus durations.

Mice from both groups appear to have learned the task equally well after advancing from the 8-s stimulus duration, as they met advancement criteria near the minimum number of days from the 4- to 1.4-s stimulus durations. An effect of developmental treatment then re-emerged at the lowest stimulus duration tested of 1 s, as mice from the ethanol treatment group again required more days to meet training criteria. This dramatic increase in days to criteria for mice from the ethanol treatment group likely resulted from the average percent omissions across all training days of 17.5 ± 1.2 (95% confidence interval = 14.9 to 20.2%), which fell close to the criterion cutoff of 20%. Errors of omission on the 5-CSRTT increased for both treatment groups as stimulus duration decreased. However, percentage of omissions was greater overall for mice from the ethanol treatment group and significantly greater by *post hoc* analysis at the lowest 1.2- and 1-s stimulus durations. In the absence of treatment effects on correct response latency or reward collection latency, which incorporate potentially confounding sensory and motor functions in addition to overall motivation ([@B84]), this suggests that mice from the ethanol treatment group exhibited impaired global attention processing ([@B53]) that was most pronounced at the lowest stimulus durations requiring the greatest attentional demand. This effect of developmental ethanol exposure to increase omissions is striking, because the 5-CSRTT version used in this study required mice to initiate each trial after a fixed ITI to self-regulate session pace ([@B53]) instead of the more widely used 5-CSRTT version originally developed for rats where trials following correct responses/reward collection are automatically initiated ([@B7]). We used this strategy because mice generally perform this task with a greater percentage of omissions than rats ([@B29]; [@B5]; [@B53]), and its use suggests that the higher rate of omissions in the ethanol treatment group cannot be attributed to mice taking longer to collect food reward or missing initiation of the next trial. Visual sensory processing was not directly tested in this study, so it remains possible that alterations to visual acuity influenced percent omissions in ethanol-treated mice. Evidence against this interpretation includes the lack of treatment effects on percent accuracy below the 8 s stimulus duration or on correct response latency at any stimulus duration, and a published finding that developmental ethanol exposure does not affect learning of a visual discrimination task ([@B54]).

Effects of developmental ethanol exposure on 5-CSRTT performance in this current study are consistent with the attention deficit profile observed in children affected by FASD. Studies in children exposed to ethanol prenatally find impairments on continuous performance tasks for sustained attention, characterized consistently by an increased omission rate ([@B13]; [@B49]; [@B39]). Moreover, although impulsivity is a major component of the ADHD behavioral profile, it is not as prevalent within the FASD behavioral profile ([@B13]; [@B39]), and we also found no treatment effect on premature responding in this study. Developmental ethanol exposure via liquid diet was recently reported to impart similar effects on rat attention performance. One study found developmental ethanol to increase percentage of omissions on the 5-CSRTT ([@B14]), whereas another study found this effect only in conjunction with developmental stress ([@B18]), and neither study observed changes to premature responding. These studies, together with our results, recapitulate the main components of the attention deficit profile in FASD, confirming that rodents are appropriate models to determine underlying neuronal mechanisms.

Developmental ethanol exposure and prefrontal layer VI pyramidal neurons {#s5B}
------------------------------------------------------------------------

We studied mPFC layer VI pyramidal neurons because approximately 40% of this neuronal population contributes to attention circuitry through the modulation of corticothalamic signal gain ([@B31]; [@B95]; [@B70]; [@B88]) and because of the potential for developmental ethanol exposure to dysregulate nicotinic support of these processes, as described above. The recording of retrograde-labeled corticothalamic projection neurons would have provided a more restricted analysis of this mPFC layer VI pyramidal neuron subtype only, allowing for direct comparisons between corticothalamic signaling and attention performance. The random sampling of pyramidal neurons that we used within layer VI alternatively allowed for the incorporation of additional pyramidal neuron subtypes that may also contribute to cognitive functions, including attention, through their projections within the medial prefrontal cortex itself and also to subcortical brain regions including the striatum, hypothalamus, and amygdala ([@B31]; [@B37]). It is important to consider the potential for developmental ethanol exposure to alter the laminar organization of the mature mPFC, which could have led to the sampling of distinct populations of pyramidal neurons within layer VI of mice from each treatment group. Although reports in mouse ([@B89]) and guinea pig ([@B4]) demonstrate normal cortical layering for primary motor/sensory cortices after developmental ethanol exposure, a detailed histological analysis of the mPFC is required to confirm these findings for this associative cortical region.

Both passive and active basic electrophysiological properties of layer VI neurons were altered by developmental binge-pattern ethanol exposure, resulting in decreased neuronal function. Decreased capacitance and a trend toward increased input resistance suggest smaller neurons in mice from the ethanol group ([@B22]), which alone could increase their passive response to positive input. However, decreased active function of these same neurons was evidenced by increased rheobase and decreased firing frequency in the range of 50- to 200-pA positive current injection. This decreased firing frequency may result from the larger AHP amplitudes measured in neurons from mice in the ethanol group, which in turn are influenced by BK and SK calcium-activated potassium channels ([@B27]; [@B78]). Although acute ethanol exposure decreases neuronal excitability through BK channels ([@B56]; [@B24]) and increases neuronal excitability through SK channels ([@B12]; [@B47]), long-term consequences of developmental ethanol exposure on these channels and their specific roles in mPFC layer VI neuron excitability remain to be determined.

The effect of developmental binge-pattern ethanol exposure to decrease intrinsic excitability of mPFC layer VI neurons is contrasted by an increase in function for excitatory nAChRs and AMPA receptors. Upregulated receptor function at the neuronal level could result from increased expression of subunit protein or from increased function of individual receptors. Pyramidal neurons in mPFC layer VI are excited directly by α4β2\* nAChRs that may exhibit augmented function from posttranslational modification ([@B35]). A proportion of α4β2\* nAChRs in layer VI neurons contain the α5 accessory subunit that increases receptor-mediated currents when present ([@B92]; [@B43]; [@B5]; [@B79]), so augmented function at the neuronal level may result from the selective increase in α5 subunit expression or incorporation into receptors. Although mPFC layer VI neurons in untreated animals are not believed to express functional α7 subunit--containing nAChRs ([@B43]; [@B79]), it is possible that the expression or function of this nAChR subtype is selectively upregulated after developmental ethanol exposure. Evidence against this possibility can be found in a follow-up study currently underway in our laboratory, in which the inhibition of α7 subunit--containing nAChRs using methyllycaconitine did not affect nAChR function in mPFC layer VI neurons after developmental ethanol exposure (data not shown). Given the large number of nAChR subunit genes and isoform combinations in the brain, it would be advantageous to complete a comprehensive analysis of subunit expression and isoform content within each neuron type of the mPFC after developmental binge-pattern ethanol exposure, to fully determine mechanisms underlying the augmented excitatory responses to ACh observed in this study. To our knowledge, the single study to examine effects of developmental ethanol exposure on nAChR content found decreased brainstem receptor number as a function of increased prenatal ethanol exposure in children who had died of sudden infant death syndrome ([@B25]).

We observed faster activation kinetics of sEPSCs in mPFC layer VI neurons after developmental binge-pattern ethanol exposure, which may reflect the faster activation of AMPA- versus kainate-mediated sEPSCs ([@B19]), suggesting an increased AMPA:kainate receptor ratio in these neurons. We also observed a trend toward increased sEPSC amplitude and significantly increased responses to direct AMPA receptor activation, which all suggest increased AMPA receptor subunit protein expression, altered subunit/splice variant composition ([@B48]), or altered association with transmembrane regulatory proteins ([@B44]). Previous studies in rat found that AMPA receptors were not affected in the hippocampus ([@B55]) and had decreased expression in whole cerebral cortex ([@B8]) after developmental ethanol exposure, which may indicate a species difference or the specificity of our observed results to mPFC layer VI pyramidal neurons. A more detailed examination of glutamatergic neurotransmission at these neurons could address these remaining questions. Potential analyses include the measurement of EPSCs that are activity-dependent (evoked EPSCs) and activity-independent (mini-EPSCs), the measurement of AMPA/Kainate/NMDA receptor function, and the analysis of AMPA/Kainate/NMDA receptor expression and biochemistry.

It should be noted that for all electrophysiological data that are determined to be significantly affected by developmental treatment, significance is also attained when the mouse is used as the unit of determination. One exception is the AMPA receptor data presented in [Figure 7](#F7){ref-type="fig"}, because these experiments were performed only in approximately one-half the mice that were used in this study, and their analyses did not attain sufficient statistical power.

Implications for prefrontal cholinergic signaling in attention {#s5C}
--------------------------------------------------------------

Cholinergic signaling within the mPFC ([@B75]; [@B21]; [@B72]), and specifically at α4β2\* nAChRs on layer VI pyramidal neurons ([@B32]), is critical for normal attention. We provide further evidence here in sucrose/control mice for the role of α4β2\* nAChRs on layer VI neurons to support attention processing, through a selective combination of correlations between receptor function and performance on the 5-CSRTT. Upregulated receptor function, impaired performance on the 5-CSRTT, and a lack of correlations between the two after developmental binge-pattern ethanol exposure suggest that this treatment may disrupt the ability of nicotinic signaling at mPFC layer VI neurons to support attention processing. Confirmation of a causal link between dysregulated nicotinic signaling at mPFC layer VI neurons and decreased attention performance after developmental binge-pattern ethanol exposure would need to be performed in future studies. For example, selective manipulation of nAChR function on mPFC layer VI neurons could be performed in control and developmental ethanol-treated rodents while they are performing the 5-CSRTT. It is important to note that the original rodent lesioning studies demonstrating a role for the mPFC to support performance on the 5-CSRTT were not performed using touchscreen equipment ([@B62]; [@B16]; [@B21]). Although these lesioning studies have not yet been repeated using the touchscreen version of the 5-CSRTT, our results add to a growing body of literature providing correlational evidence that the mPFC also supports mouse performance on this version of the task ([@B61]; [@B66]).

We did not expect decreased performance on the 5-CSRTT in the ethanol treatment group to be associated with increased nAChR function in mPFC layer VI neurons because signaling at this receptor normally supports attention processing. However, it should be noted that these neurons display a generally dysregulated profile that also includes decreased intrinsic excitability, and it is not currently known whether nAChR function is upregulated to compensate for decreased intrinsic excitability or intrinsic excitability is downregulated to compensate for increased nAChR function. Moreover, the net effect of these neurophysiological outcomes of developmental ethanol exposure on the function of mPFC layer VI neurons within *in vivo* attention circuitry is not known. It should also be noted that agonist augmentation of nAChR function in rodents exhibits a U-shaped curve for performance in attention tasks ([@B60]; [@B33]; [@B34]), suggesting another explanation for our data that nAChR function within mPFC layer VI neurons requires a tight operational range to optimally support attention. In conclusion, our findings demonstrate novel mechanisms underlying dysregulation of prefrontal attention circuitry after developmental binge-pattern ethanol exposure and suggest the remediation of mPFC layer VI neuron function as a potential therapeutic target to mitigate attention deficits in FASD.
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Synthesis {#s6}
=========

The decision was a result of the Reviewing Editor Tim Bussey and the peer reviewers coming together and discussing their recommendations until a consensus was reached. A fact-based synthesis statement explaining their decision and outlining what is needed to prepare a revision is listed below. The following reviewers agreed to reveal their identity: Carlos Valenzuela, Christopher Heath

reviewers The and I felt that your study was interesting, well-written, and valuable. There are a few issues, however, that still need to be addressed. A main issue that came out of the reviews and our consultation is the \"unit of determination\" (litter, pup, cell) used in the analysis of each experiment. In particular, it needs to be confirmed that averaged recordings are from slices from a pup and the pup is the unit of determination. Both reviewers also agree that it should be made clear what exactly the ethanol exposure paradigm is modelling (e.g., binge drinking, see reviewer 1\'s comment 3 below; FASD, see reviewer 2). Both reviewers also agree that the correlations shown in Fig 8 add little to the report and should be removed. Finally, each reviewer has more minor comments that need to be addressed. If these changes are thorough and clear, I hope to be able to evaluate them myself without sending the manuscript back to the reviewers. Both reviews are reproduced in full below.

Reviewer 1

The paper of Louth et al reports that chronic prenatal ethanol exposure impaired performance on the five-choice serial reaction time test. Slice electrophysiological experiments revealed functional alterations in pyramidal neurons in layer VI of the medial prefrontal cortex, including increased responses to agonists of nAChRs and AMPA receptors. The paper is well-written and results are compelling and interesting. This paper was previously submitted for consideration to J. Neurosci and has now been transferred to eNeuron. The authors appropriately addressed the concerns raised by the reviewers of the original submission. There are only a few issues for the authors\' consideration:

1\. The shunting effects of GABAA receptor activation (including via tonic currents) should still influence neuronal function even at the chloride equilibrium potential. The investigators may want to comment on whether this could affect interpretation of results.

2\. In my opinion, the correlations shown in Fig 8 add little to the paper and removing them would not detract from the study. In order to provide a conclusive link between the alterations in receptor function and the behavioral deficits, selective manipulation of the function of this receptors in Layer VI pyramidal neurons would be required. The behavioral results could be presented as part of the general characterization of the ethanol exposure paradigm and in the discussion it could be acknowledged that receptor alterations may contribute to these effects but that additional experiments would be required to address this issue.

3\. The ethanol exposure paradigm appears to model binge ethanol exposure. The authors may want to emphasize this a bit more, including discussion of % of women that binge drink during pregnancy and whether this pattern of ethanol exposure is more damaging to the CNS than non-binge exposure.

4\. Please clarify and justify the choice of unit of determination (litter, pup, cell) for each experiment. In Tables 3 and 4, both the number of mice and neurons are provided and it needs to be clarified which one of these was used for statistical analyses.

5\. Fig 6. Please also provide average traces illustrating differences in rise time and/or decay time.

Reviewer 2

Taken together, the data presented in this manuscript are timely and impactful, providing a well-executed behavioural and electrophysiological characterisation of a mouse model of perinatal ethanol exposure upon which a number of future studies can be based.

In my view the authors have also effectively addressed the comments made by the Reviewers of the previous version of the manuscript. The lack of identification of the targets for the recorded layer VI neurons does weaken the interpretation of the findings with respect to attentional mechanisms, given the acknowledged heterogeneity in these projections. However, this should be balanced with the existing data, the detailed discussion of the caveats given by the authors and the length and complexity of the procedure necessary to generate the additional animals to address this issue. As such, I believe the manuscript is suitable for publication in eNeuro, although there are a small number of issues the authors should be asked to address prior to final acceptance.

Major concerns:

1\. The authors note that the mice involved in the study were drawn from multiple litters but that there wasn\'t a 1:1 correlation between the number of mice used and the number of litters produced. Can the authors specify the maximum number of animals drawn from any one litter to ensure that the reported effects are not confounded by an overrepresentation of a limited number of litters?

Minor concerns:

1\. In the significance statement the authors state that the perinatal ethanol exposure model used in the manuscript is a \'mouse model of FASD\'. Such a statement is not made elsewhere in the manuscript and no literature support is provided. Can the authors confirm that this exposure paradigm is considered an FASD model?

2\. In the Introduction the authors note (on lines 102 - 104) that 40% of corticothalamic neurons project to the thalamic reticular nucleus - is this not the mediodorsal projection?

3\. Can the authors explain why the BEC determination was performed using mice exposed to ethanol between P4 and P10 and not P4 and P14 to be consistent with the mice used in the rest of the study?

4\. The frequency and duration of tone used in the 5-choice serial reaction time task (line 213) should be added.
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